MAPT and early-onset autosomal dominant Alzheimer disease: The biosignatures were associated with the Alzheimer’s disease CSF biomarker profiles of ATN (amyloid, phosphorylated tau and neurodegeneration pathology), yet only to a small extent with clinical diagnosis, cognition and imaging biomarkers.